COVID-19: Don’t let the guard down, caution experts
If caution is thrown to the wind, we could well be laying out an invitation for a second wave, which the country can ill afford. (PTI Photo/File) If there are…
COVID-19 vaccine: Case now to ramp up supplies at lower prices, says expert
Almost all the major platforms to make the vaccines are being carried out in India by at least half a dozen leading Indian vaccine companies and many smaller companies. (AP…
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective…
Deliverance 2021: Indian firms up cold storage & vial supplies as govt readies vaccine roll out
In the space for glass vials needed for the vaccines, companies have been expanding capacities and ramping up supplies. (AP image/Representational picture)Deliverance in the new year will come encased in…
Covid-19 vaccination: Can’t deny chances of an adverse event, states told to be prepared, says health secretary
India's Case Fatality Rate (CFR) is 1.45 per cent, whereas globally it is 2.26 per cent, Bhushan avered, adding that India's CFR is among the lowest in the world. (Representational…
Coronavirus Vaccine update: Pfizer’s Covid-19 vaccine is in ‘very advanced stage’, final results expected in October
Coronavirus Vaccine news, update: Pfizer’s statement has come after US President Donald Trump announced that a vaccine could come before the November 3 US Presidential election.Coronavirus Vaccine news, update: Coronavirus vaccine…
Coronavirus vaccine by Oxford-AstraZeneca is ‘very close to the end’, claims Donald Trump
Coronavirus vaccine update: Last month Donald Trump had said that it was possible the United States would have a coronavirus vaccine before the November 3 election. (Reuters image)Coronavirus vaccine update: Oxford-AstraZeneca’s…
First Coronavirus Vaccines may not be most effective, second line of defence is key, warn experts
Coronavirus vaccine update: So far, eight vaccine candidates are leading the race. (Reuters image)Coronavirus vaccine update: Initial Coronavirus vaccines might not be the most effective against COVID-19, experts have warned. However,…
Coronavirus Vaccine: US-based Moderna’s COVID-19 vaccine shows similar effectiveness among old, young age groups
Results of Moderna’s vaccine have so far shown that older people were found to be more vulnerable to the highly contagious disease. (Reuters image)Coronavirus update, COVID19 vaccine tracker: US-based Moderna’s…
Health ministry recommends COVID tests for all tuberculosis patients and vice versa
The prevalence of tuberculosis among COVID-19 patients has been found to be 0.37 to 4.47 per cent in different studies, the ministry said. (Representational image)Tuberculosis is associated with a 2.1-fold…